AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 12/07/22 GMT
11,258.00UNCH (UNCH)
52 week range
8,090.32 - 11,540.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11,258.00
  • 52 Week High11,540.00
  • 52 Week High Date08/25/22
  • 52 Week Low8,090.32
  • 52 Week Low Date12/07/21

Key Stats

  • Market Cap211,482.21M
  • Shares Out1,549.51M
  • 10 Day Average Volume1.26M
  • Dividend221.70
  • Dividend Yield1.97%
  • Beta0.31
  • YTD % Change29.73

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11,258.00
  • 52 Week High11,540.00
  • 52 Week High Date08/25/22
  • 52 Week Low8,090.32
  • 52 Week Low Date12/07/21
  • Market Cap211,482.21M
  • Shares Out1,549.51M
  • 10 Day Average Volume1.26M
  • Dividend221.70
  • Dividend Yield1.97%
  • Beta0.31
  • YTD % Change29.73

RATIOS/PROFITABILITY

  • EPS (TTM)117.93
  • P/E (TTM)95.46
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/11/2022
  • Div Amount76.40
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Related Video

Options Action: A bet against AstraZeneca
VIDEO1:1201:12
Options Action: A bet against AstraZeneca

Profile

MORE
AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development....
Michel Demare
Non-Executive Independent Chairman of the Board - Designate
Leif Johansson
Independent Non-Executive Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom